Nykode Therapeutics
NYKD.OL
$1.37
Share price
-0.41%
Change (1 day)
-42.75%
Change (1 year)
Categories
Nykode Therapeutics (NYKD.OL) - Cash on Hand
Cash on Hand as of December 2023 : $0.16 B
According to Nykode Therapeutics's latest financial reports the company has $0.16 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nykode Therapeutics - Cash on Hand chart (from 2020 to 2020)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.20 B | -9.69% |
| 2021-12-31 | $0.22 B | 9.41% |
| 2020-12-31 | $0.20 B | 5713.45% |
| 2019-12-31 | $3.58 M | 87.89% |
| 2018-12-31 | $1.9 M | -37.74% |
| 2017-12-31 | $3.06 M |